Ad
related to: is ibuprofen banned in india list of brands alphabetical
Search results
Results From The WOW.Com Content Network
Ibuprofen, an analgesic and non-steroidal anti-inflammatory drug (NSAID), [1] is sold under many brand-names around the world. The most common are Brufen (its earliest registered trademark), Advil, Motrin, and Nurofen .
Schedule H1: Notified in 2013 [5], this list includes third and fourth generation antibiotics, some psychotropic drugs and anti-TB drugs. A separate register is to be maintained to track supply of these drugs and labelling requirements are of the symbol "Rx" and the red boxed warning : “Schedule H1 Drug-Warning: It is dangerous to take this ...
List of cigar brands; List of cigarette brands; List of defunct consumer brands; List of digital camera brands; Dunlop (brands) List of electronics brands; List of firearm brands; List of perfumes; List of chained-brand hotels; List of ibuprofen brand names; List of Icelandic brands; List of company and product names derived from indigenous peoples
Drugs with similar structures and biological activity are also banned because new designer drugs of this sort are always being developed in order to beat the drug tests. Caffeine, a stimulant known to improve performance, is currently not on the banned list. It was listed until 2004, with a maximum allowed level of 12 micrograms per millilitre ...
Schedule H is a class of prescription drugs in India appearing as an appendix to the Drugs and Cosmetics Rules, 1945 introduced in 1945. These are drugs which cannot be purchased over the counter without the prescription of a qualified doctor.
The following list mentions the names of all substances banned or controlled in India under the NDPS Act. The list uses the International Nonproprietary Name (INN) of the drugs but in some cases mentions drugs by their chemical name. Widely known drugs such as ganja, cocaine, heroin etc. are mentioned by those names.
This list is not limited to drugs that were ever approved by the FDA. Some of them (lumiracoxib, rimonabant, tolrestat, ximelagatran and ximelidine, for example) were approved to be marketed in Europe but had not yet been approved for marketing in the US, when side effects became clear and their developers pulled them from the market.
Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs, ranked by sales. Abbreviations are used in the list as follows: INN = International Nonproprietary Name; BAN = British Approved Name; USAN = United States Adopted Name; Two-letter codes for countries